Celis E - Search Results

1

Design and testing of peptide-based cytotoxic T-cell-mediated immunotherapeutics to treat infectious diseases and cancer.

Chesnut RW, Sette A, Celis E, Wentworth P, Kubo RT, Alexander J, Ishioka G, Vitiello A, Grey HM. Chesnut RW, et al. Among authors: celis e. Pharm Biotechnol. 1995;6:847-74. doi: 10.1007/978-1-4615-1823-5_38. Pharm Biotechnol. 1995. PMID: 7551252 Review. No abstract available.

2

Epitope selection and development of peptide based vaccines to treat cancer.

Celis E, Sette A, Grey HM. Celis E, et al. Semin Cancer Biol. 1995 Dec;6(6):329-36. doi: 10.1016/1044-579x(95)90002-0. Semin Cancer Biol. 1995. PMID: 8938271 Review.

3

Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes.

Celis E, Tsai V, Crimi C, DeMars R, Wentworth PA, Chesnut RW, Grey HM, Sette A, Serra HM. Celis E, et al. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2105-9. doi: 10.1073/pnas.91.6.2105. Proc Natl Acad Sci U S A. 1994. PMID: 7510885 Free PMC article.

4

Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules.

Ruppert J, Sidney J, Celis E, Kubo RT, Grey HM, Sette A. Ruppert J, et al. Among authors: celis e. Cell. 1993 Sep 10;74(5):929-37. doi: 10.1016/0092-8674(93)90472-3. Cell. 1993. PMID: 8104103

5

Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome.

Wentworth PA, Sette A, Celis E, Sidney J, Southwood S, Crimi C, Stitely S, Keogh E, Wong NC, Livingston B, Alazard D, Vitiello A, Grey HM, Chisari FV, Chesnut RW, Fikes J. Wentworth PA, et al. Among authors: celis e. Int Immunol. 1996 May;8(5):651-9. doi: 10.1093/intimm/8.5.651. Int Immunol. 1996. PMID: 8671652

6

Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules.

Sidney J, Grey HM, Southwood S, Celis E, Wentworth PA, del Guercio MF, Kubo RT, Chesnut RW, Sette A. Sidney J, et al. Among authors: celis e. Hum Immunol. 1996 Feb;45(2):79-93. doi: 10.1016/0198-8859(95)00173-5. Hum Immunol. 1996. PMID: 8882405

7

In vitro immunization and expansion of antigen-specific cytotoxic T lymphocytes for adoptive immunotherapy using peptide-pulsed dendritic cells.

Tsai V, Kawashima I, Keogh E, Daly K, Sette A, Celis E. Tsai V, et al. Among authors: celis e. Crit Rev Immunol. 1998;18(1-2):65-75. doi: 10.1615/critrevimmunol.v18.i1-2.80. Crit Rev Immunol. 1998. PMID: 9419449 Review.

8

Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses.

Oseroff C, Sette A, Wentworth P, Celis E, Maewal A, Dahlberg C, Fikes J, Kubo RT, Chesnut RW, Grey HM, Alexander J. Oseroff C, et al. Among authors: celis e. Vaccine. 1998 May;16(8):823-33. doi: 10.1016/s0264-410x(97)00264-8. Vaccine. 1998. PMID: 9627940

9

Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules.

Kondo A, Sidney J, Southwood S, del Guercio MF, Appella E, Sakamoto H, Celis E, Grey HM, Chesnut RW, Kubo RT, Sette A. Kondo A, et al. Among authors: celis e. J Immunol. 1995 Nov 1;155(9):4307-12. J Immunol. 1995. PMID: 7594589

10

In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides.

Wentworth PA, Celis E, Crimi C, Stitely S, Hale L, Tsai V, Serra HM, Del Guercio MF, Livingston B, Alazard D, Fikes J, Kubo RT, Grey HM, Chesnut RW, Chisari FV, Sette A. Wentworth PA, et al. Among authors: celis e. Mol Immunol. 1995 Jun;32(9):603-12. doi: 10.1016/0161-5890(95)00037-f. Mol Immunol. 1995. PMID: 7643853

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters